Indapamide is as effective as captopril in the control of microalbuminuria in diabetes

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 3, 1996, Pages 424-427

  Molyneaux, L M ^a   Willey, K A ^a   Yue, D K ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Diabetes; Indapamide; Macrovascular disease; Microalbuminuria

Indexed keywords

CAPTOPRIL; CHOLESTEROL; HEMOGLOBIN A1C; INDAPAMIDE; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COUGHING; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; PRIORITY JOURNAL; RASH; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; CROSS-OVER STUDIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INDAPAMIDE; MALE; MIDDLE AGED;

EID: 0030069861     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199603000-00016     Document Type: Article

References (29)

1. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-2.
2. Mogensen CE. Microalbuminuria predicts clinical protein- uria and early mortality in maturity onset diabetes. N Engl J Med 1984;310:356-60.
3. Steigler H, Standl E, Schulz K, Roth R, Lehmacher W. Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabetic Med 1992;9:646-53.
4. Jensen T, Borch-Johnsen K, Koefed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulin- dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987;30:144-8.
5. Mogensen CE, Chachati A, Christensen CK, et al. Microal- buminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985-6;9:85-95.
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
7. Stornello M, Valvo EV, Puglia N, Scapellato L. Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria. J Hypertension 1988;6(suppl 4):S464-6.
8. Stornello M, Valvo EV, Scapellato L. Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria. J Hypertens 1989;7(suppl 6): S314-5.
9. Stornello M, Valvo EV, Vasques E, Leone S, Scapellato L. Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients. J Hypertens 1989;7(suppl 7):S65-7.
10. Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;112:707-8.
11. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WE. Effect of antihypertensive therapy on the kidney in patients with diabetes: a metaregression analysis. Ann Intern Med 1993;118:129-38.
12. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990;33:470-6.
13. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991;302:210-6.
14. Gambardella S, Frontoni S, Lala A, et al. Regression of microalbuminuria in type II diabetic hypertensive patients after long-term indapamide treatment. Am Heart J 1991;122:1232-8.
15. Flack JR. Molyneaux L, Willey K, Yue DK. Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. J Cardiovasc Pharmacol 1993;22(suppl 6): S75-7.
16. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81.
17. Romero R, Salinas I, Lucas A, et al. A Renal function changes in microalbuminuric normotensive type II diabetic patients with angiotensin-converting enzyme inhibitors. Diabetes Care 1993;16:597-600.
18. Marre M, Chatellier G, Leblanc H, Guyenne TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988;297:1092-5.
19. Parving HH, Hommel E, Nielsen MD, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 1989;299:533-6.
20. Mathiesen ER, Hommel E, Geise AJ, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991;303:81-7.
21. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbumin- uria. JAMA 1994;271:275-9.
22. Lacoucière Y, Nadeau A, Poirier L, Tancrède G. Captopril or conventional therapy in hypertensive type II diabetics. Three year analysis. Hypertens 1993;21:786-94.
23. Opie LH. ACE inhibitors: Side-effects and contraindications. In: Opie LH. Angiotensin converting enzyme inhibitors: scientific basis for clinical use. New York: Author's Publishing House, 1992:194-202.
24. Wheeley MS, Bolton JC, Campbell DB. Indapamide in hypertension: a study in general practice of new or previously poorly controlled patients. Pharmatherapeutica 1982;3:143-52.
25. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorthiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-73.
26. Raggi U, Palumbo P, Mero B, Bevilacqua M, Norbiato G. Indapamide in the treatment of hypertension in non-insulin dependent diabetes. Hypertension 1985;7:(suppl 11):157-60.
27. Beling S, Vukovich RA, Neiss ES, Zisblatt M, Webb E, Losi M. Long term experience with indapamide. Am Heart J 1983;106(suppl 2):258-62.
28. Weidmann P, Bianchetti MG, Mordasini R. Effects of indapamide and various diuretics alone or combined with beta- blockers on serum lipoprotein. Curr Med Res Opin 1983;8 (suppl 3): 123-34.
29. Meyer-Sabellek W, Heitz J, Arntz HR, Schulte K-L, Gotzen R. The influence of indapamide on serum lipoproteins. Methods Find Exp Clin Pharmacol 1984;6:471-4.